Compares implanted port outcomes by breast cancer side during chemotherapy
Looks back at how chest ports fared in breast cancer patients receiving chemotherapy.
Plain-language title generated from the registry record
Registry title: Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy
Key facts
- Where
- Gorgan, IranSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial looks back at women with breast cancer who had a chemotherapy port placed in the right jugular vein from 2017 to 2024. It compares right-sided and left-sided breast cancer.
- Sex
- Women with breast cancer
- Disease stage
- Breast cancer on the right or the left side
- Earlier treatment
- Had a chemotherapy port placed through the right internal jugular vein between 2017 and 2024 in Gorgan medical centers
Main reasons for not taking part
- Earlier neck surgery involving the right jugular area
- Earlier radiotherapy involving the right jugular area
- Incomplete medical records
Read by machine on 12 November 2026.
Where in Iran
- 5Th Azar Medical CenterGorgan, IranContact: Pezhman KharazmNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Golestan University of Medical sciences
- Trial code
- NCT07197320
- Record updated
- 29 September 2025
- Original description
Chemotherapy is an essential component of breast cancer treatment. Frequent intravenous injections may lead to phlebitis and limited venous access, therefore implantable venous ports are increasingly used. The choice of port placement side in breast cancer patients is controversial, especially when mastectomy or radiotherapy is planned. This retrospective cohort study compares one-year patency, complications (infection, thrombosis, skin necrosis), and functional outcomes of ports implanted via the right internal jugular vein in patients with right versus left breast cancer.Read full original descriptionShow less
Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy in Gorgan Medical Centers (2017-2024)
Chemotherapy is an essential component of breast cancer treatment. Frequent intravenous injections may lead to phlebitis and limited venous access, therefore implantable venous ports are increasingly used. The choice of port placement side in breast cancer patients is controversial, especially when mastectomy or radiotherapy is planned. This retrospective cohort study compares one-year patency, complications (infection, thrombosis, skin necrosis), and functional outcomes of ports implanted via the right internal jugular vein in patients with right versus left breast cancer.
Inclusion: Female patients with breast cancer (right or left side); Underwent chemotherapy port implantation via right internal jugular vein between 2017-2024 in Gorgan medical centers.
Exclusion: Prior neck surgery or radiotherapy involving right jugular area; Incomplete medical records.